ABSTRACT
The world is currently facing a global challenge against neoplastic diseases. Chemotherapy, hormonal therapy, surgery, and radiation therapy are some approaches used to treat cancer. However, these treatments are frequently causing side effects in patients, such as multidrug resistance, fever, weakness, and allergy, among others side effects. As a result, current research has focused on phytochemical compounds isolated from plants to treat deadly cancers. Plants are excellent resources of bioactive molecules, and many natural molecules have exceptional anticancer properties. They produce diverse anticancer derivatives such as alkaloids, terpenoids, flavonoids, pigments, and tannins, which have powerful anticancer activities against various cancer cell lines and animal models. Because of their safety, eco-friendly, and cost-effective nature, research communities have recently focused on various phytochemical bioactive molecules. Ursolic acid (UA) and its derivative compounds have anti-inflammatory, anticancer, apoptosis induction, anti-carcinogenic, and anti-breast cancer proliferation properties. Ursolic acid (UA) can improve the clinical management of human cancer because it inhibits cancer cell viability and proliferation, preventing tumour angiogenesis and metastatic activity. Therefore, the present article focuses on numerous bioactivities of Ursolic acid (UA), which can inhibit cancer cell production, mechanism of action, and modulation of anticancer properties via regulating various cellular processes.
Acknowledgement
The authors extend their appreciation to the Deanship of Scientific Research, Jazan University, for supporting this research work through the Research Units Support Program: Support Number. RUP-2-04.
Disclosure statement
No potential conflict of interest was reported by the authors.
Correction Statement
This article has been republished with minor changes. These changes do not impact the academic content of the article.
Additional information
Funding
Notes on contributors
Sardul Singh Sandhu
Sardul Singh Sandhu is Professor at Rani Durgavati University, Jabalpur, M.P. India and is currently the Director of the Design Innovation Center, Rani Durgavati University. His research interests include microbiology, plant-microbe interactions, the endophytic microbiome, molecular biology innovation and bio-design. Prof.Sandhu has published more than 200 publications in international reputed journals.
Sharareh Khorami Rouz
Sharareh Khorami Rouz is associated with the School of Life Sciences, Manipal Academy of Higher Education, Dubai, United Arab Emirates.
Suneel Kumar
Suneel Kumar is Research Fellow at Bio-Design Innovation Centre, Rani Durgavati University, Jabalpur (M.P.) India. His fields of interest are endophyte and plant microbes’ interaction.
Nitin Swamy
Nitin Swamy is a PhD student studying at FBIPL, Department of Biological Sciences, Rani Durgavati University, Jabalpur (M.P.) India.
Loknath Deshmukh
Loknath Deshmukh is presently working as Assistant Professor at ITM University Raipur. He has completed my PhD degree in Interspecific Hybridization Technology. He has 7 years of experience in the research field.
Arif Hussain
Arif Hussain is associated with the School of Life Sciences, Manipal Academy of Higher Education, P.O. Box 345050, Dubai, United Arab Emirates
Shafiul Haque
Shafiul Haque: is associated with Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia. He is a part of the Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Hardeep Singh Tuli
Hardeep Singh Tuli is a researcher and academic with a high predilection toward research. He is currently working in the Department of Biotechnology, Maharishi Markandeshwar Engineering College Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India.